Stephen Hubbard in the Bay (@StephenGHubbard) header
Stephen Hubbard in the Bay (@StephenGHubbard) profile picture

Strategic Partnerships, @Synbiobeta Development, @NeuroAgeTX Founder, @BiotechBarbellClub - https://teapaw.org/t.co/lPVqQ1b4Al

San Francisco
Joined June 2009
Photo by Stephen Hubbard in the Bay (@StephenGHubbard)Photo by Stephen Hubbard in the Bay (@StephenGHubbard)Photo by Stephen Hubbard in the Bay (@StephenGHubbard)Photo by Stephen Hubbard in the Bay (@StephenGHubbard)Photo by Stephen Hubbard in the Bay (@StephenGHubbard)Photo by Stephen Hubbard in the Bay (@StephenGHubbard)Photo by Stephen Hubbard in the Bay (@StephenGHubbard)Photo by Stephen Hubbard in the Bay (@StephenGHubbard)Photo by Stephen Hubbard in the Bay (@StephenGHubbard)Photo by Stephen Hubbard in the Bay (@StephenGHubbard)
Stephen Hubbard in the Bay retweeted
Damn straight
Stop complaining about having to exercise and be grateful for the fact that you have the ability to do it.
1
7
386
Stephen Hubbard in the Bay retweeted
My take on the automated labs for biology discussion: The hard thing about biology is the biology
18
29
6
350
28,686
The wider the cone of illuminated knowledge, the larger is our perimeter of unknown darkness.
Biology is a nearly endlessly complex black box that we only uncover answers where we look. AI will accelerate this progress dramatically but we are so early and so incredibly far from “solving” this science.
1
3
171
Stephen Hubbard in the Bay retweeted
The Singularity is coming for Physics and Biology. RIP Math.
105
652
113
6,867
643,076
Stephen Hubbard in the Bay retweeted
No longer mourn for me when I am dead Than you shall hear the surly sullen bell Give warning to the world that I am fled From this vile world with vilest worms to dwell; Nay, if you read this line, remember not The hand that writ it; for I love you so, That I in your sweet thoughts would be forgot, If thinking on me then should make you woe. O, if (I say) you look upon this verse, When I (perhaps) compounded am with clay, Do not so much as my poor name rehearse, But let your love even with my life decay, Lest the wise world should look into your moan, And mock you with me after I am gone.
5
21
1,450
Stephen Hubbard in the Bay retweeted
When I was a kid there was a TV show about a space ship where humans met the universe with competence, nobility, and expansive, powerful compassion. This is still the future worth living in and the one worth fighting for
In lieu of flowers, memorial contributions may be made to: Johns Hopkins Alzheimer’s Disease Research Center Fund    alzresearch.org/giving/ Alzheimer’s Foundation of America Caregiver Resources     alzfdn.org/donate/ Photo Credit: Tommy Garcia
3
61
2
410
4,664
Stephen Hubbard in the Bay retweeted
this week we've had RFD4-Proteina @UWproteindesign, Omnii-1 @RadicalNumerics, scorpion minibinders @AnthropicAI, lab digital twins @GoogleResearch... this is too much, guys, I cannot read all these blog posts let alone these papers
2
3
28
1,068
This guy reads The Inner Game of Tennis
No exaggeration, this guy might be the best interview in pro sports right now
1
216
One of the best concise explainations of synthetic biology from @PeterDiamandis If this is interesting to you, I hope you'll join us at @SynBioBeta 2027
I'm excited to share something I've been working on... NeoGenesis Capital is a new fund focused on the intersection of superintelligence and synthetic biology. I believe some of the most extraordinary breakthroughs of the coming decade will happen at this intersection. I'll be sharing more on @moonshots_pod soon, including why I'm so excited about what's ahead!
1
5
547
Stephen Hubbard in the Bay retweeted
Congratulations to @lifeext @KEricDrexler for having co-founded an organization that was unusually early, often right, and always prescient when it comes to envisioning and building flourishing futures defined by the interplay of strong technology - from molecular nanotechnology, longevity escape velocity, sovereign AI, to neurotechnology. You were the reason I packed up my life a decade ago to move to the Bay and I've been grateful for that every day since.
40 years ago today, October 8, 1986, Foresight Institute was incorporated on a single typed page in Washington, DC. Co-founders Christine Peterson and Eric Drexler shared a conviction: to take seriously the technologies that could significantly enhance the human condition, back the people whose work is too ambitious or too interdisciplinary for legacy institutions, and give them somewhere to find each other. Follow story in thread.
3
14
7
111
9,989
Stephen Hubbard in the Bay retweeted
If you work in biomanufacturing in the Bay Area, the @agilebiofoundry Fall 2026 Industry Day in Berkeley on October 26 is a must attend. Registration closes this Monday, October 12. ABF is the DOE national lab consortium building tools, processes, and partnerships for industrial biomanufacturing. Industry Day is where companies bring real scale-up problems and the labs show what they can do about them. Industry perspective talks from: - Magdalena Stoeva of @powbio - @markvanzee of @sakubiosciences - Michael Wang of @ZymoChem The day also includes: - Lightning talks on synbio, AI, automation, and scale-up - Panels on AI and automation, host onboarding, and metabolic intermediates - The launch of the ABF Industry Accelerator - 1:1 meetings with ABF scientists - An optional tour of a local scale-up facility Hotel Shattuck Plaza, 8 AM to 5 PM. Some sessions stream virtually, but the roundtables and 1:1s are the reason to show up in person. Register: agilebiofoundry.org/fall-202…
🤖 Made with AI
1
6
15
1,177
Stephen Hubbard in the Bay retweeted
Excited to announce two of our keynote speakers for @SynBioBeta 2027: @geochurch, founder of more than 50 companies in the synthetic biology space, and @alexrives, who runs @biohub. Church's list includes @editasmed, Nebula Genomics, Veritas Genetics, GRO Biosciences, Rejuvenate Bio, @ManifoldBio, Gen9, Form Bio, and @itiscolossal, now at a $10.3B valuation. He developed the first direct genome sequencing method, helped initiate the Human Genome Project, started @PGorg in 2005, and runs the synthetic biology platform at @WyssInstitute. He teaches at @Harvard and @MIT. This year alone, Colossal partnered with US Fish and Wildlife to biobank every endangered species and published a gene drive plan to eliminate the New World screwworm in the US. Rives founded and led the ESM project at Meta's FAIR lab, which built the first large transformer language models for proteins, then spun @EvoscaleAI out with his former Meta colleagues after Meta shut the team down in 2023. That company raised $142M from Nat Friedman, Daniel Gross, @Lux_Capital, Amazon, and NVIDIA's NVentures and shipped ESM3, a 98B parameter model trained on 2.78B protein sequences that reasons over sequence, structure, and function at once. CZI acquired EvolutionaryScale in November 2025 and folded it into Biohub, with Rives as head of science. In May, that team released ESMFold2 and the ESM Atlas, mapping 6.8B sequences and 1.1B predicted structures to protein function. A month later they reported binder hits against five cancer and immune targets. The models are distributed through AWS Bio Discovery and SandboxAQ. He is also core faculty at @BroadInstitute and an assistant professor in EECS at @MIT. Two people making the same bet from opposite ends of the field. Rives came out of an AI lab and treats sequence, structure, and function as a single modeling problem, which is what moves a team from a disease target to a candidate binder in months instead of years. Church has been on the discovery side since 1984, when he published the first direct genome sequencing method, and has spent the four decades since turning academic work into CRISPR editing, recoded genomes, and a company list longer than most venture portfolios. That is the pairing we are programming around for 2027: the frontier AI labs that have moved inside biology, and the academic lineage that built the tools they train on. And this is just the start. We have an incredibly exciting speaker list coming together, and we will be announcing names over the coming months. Keep an eye out. SynBioBeta 2027 is May 3 to 6 at the San Jose McEnery Convention Center, and it is set to be our best conference yet. syntheticbiologysummit.com/?…
1
6
2
25
3,923
So glad to see important projects for Humanity being mapped out in ways that enable distributed collaboration and contribution.
I've attempted to map everything in oncology in a public website and open source repo for all. The site is trying to get all cancers, products, technologies, bottlenecks, people, startup opportunities with 1000+ ideas for upgrading the field. If you have a loved one with cancer and you are technical or can engineer, go take a look, file improvement requests or bugs or help with the open repo and make this the best open and free info resource for individuals, researchers and educational use. This should save people time, aid AI oncology projects and generate positive action. If you are not technical just complain in this thread about broken or annoying or things you want and I'll fix them live. Some of the interesting pages: Treatments: onco.cc/drugs A gallery of the molecules being used onco.cc/molecules/ And targets: onco.cc/targets/ The technologies in oncology: onco.cc/technologies/ 1100 ideas for helping oncology: onco.cc/ideas/ Bottlenecks on oncology: onco.cc/bottlenecks/ Open questions (LETS GO RESEARCH PEOPLE) onco.cc/open-questions/ Startup requests (LETS GO STARTUP PEOPLE) onco.cc/startup-requests/ Mechanics of cancer: onco.cc/mechanics Battlefronts: onco.cc/fronts/ Isotope supply: onco.cc/isotopes Key papers: onco.cc/key-papers Pipeline funnels: onco.cc/pipeline Cancer by type: onco.cc/cancers/ Institutional rankings: onco.cc/institutions/ The startups: onco.cc/startups/ Heros and heroines : onco.cc/heroes/ Key medical people: onco.cc/people/ Here is the project roadmap: onco.cc/roadmap/ Models and data sets: onco.cc/models/ There are other views as well, take a browse. Try making a PR if you have an upgrade to this on the repo here: github.com/judegomila/OnCo If you are biologically/medically minded and something is wrong, file a bug as well or say on the thread and we will get it fixed live. If this is a useful project star the repo and help get it calibrated. I've tried to add some other languages but I cannot speak them so tell me if that doesnt work well. I believe we will crack oncology and having total information dominance is key to the problem. Let the feedback flow!
1
1
5
760
?¿? #BioTwitter: Why aren't governments $incentivizing$ would-be mothers to use IVF for monozygotic twins? The ultimate natural experiment...built-in control group to decode nature vs. nurture and diseases. Investing in twin births is investing in medical breakthroughs. 🧬
17
134
Build the Fun version of this...
Regarding a cure for "most human disease in ~5-10 years" I'm not going to weigh in on if it can be done. I know how hard biotech is. But we live in interesting times and I prefer to remain open to the astonishing. Instead, assuming Anthropic is really going to try this, I'll offer my advice on how it might be fun instead of miserable. For context, biotech people are miserable sons of bitches. They won't believe you can do anything until it's done. So the baseline expectation for any project like this is scientists calling you a grifter for 10 years. Not a great time. The tech world is more comfortable with bold claims. They'll cheer for the ambition. But tech has the attention span of a goldfish. They'll get bored after 6 weeks if they don't see progress. Also not fun. The way you win over both of these groups is by building in public. I don't mean write a monthly blog post. Bring people inside the lab. 24-hour drug docking live streams. A YouTube maker channel for your lab automation hardware builds. VTubers doing target ID. Battlebots for antibody drugs. Monitoring the Situation but they only post hit-to-lead updates. Give the biologists so much open data that they're too busy analyzing it to be snarky. Succeed or fail, let the world watch this astonishing thing as it happens. Build the fun version of this.
1
210
Stephen Hubbard in the Bay retweeted
The LLMs are winning Fields medals — usually the domain of formally educated PhD mathematicians who train for years and reason on hard problems with every ounce of brilliance they have. Yes, training datasets matter. Yes, causal perturbations matter. Yes, depth of phenotyping matters. Yes, there is bias in published literature. Yes to all the critiques :) But maybe — just maybe — we should suspend our disbelief in the biotech community just a little bit and make sure we are taking the LLM capabilities for a real spin in every way that we possibly can…
9
10
2
75
13,663
How's everyone's fast-takeoff planning going?
1
247
The Biotech Barbell Club is hosting our next group lifting workout in San Diego at @IAmBiotech Conference on Sunday June 21st . Join us! It's great to lift with biotech professionals from all over the world before the biggest conferences of the year. luma.com/wxkt4j40
2
98
Stephen Hubbard in the Bay retweeted
Anthropic Says Life Sciences Is Its Biggest Bet After Code. Eric Kauderer-Abrams started @AnthropicAI 's life sciences division ten months ago. He took on the stage at @SynBioBeta with Marc Tessier-Lavigne from @Xaira_Thera , and what caught my attention was how plainly Eric stated the following: "The greatest opportunity to have a beneficial, scaled impact with everything that's happening in frontier AI is in the life sciences." After coding, it's their biggest investment area. They've been training Claude on bioinformatics, chemistry, molecule design, structural biology, clinical regulatory. Their models went from mediocre in life sciences to roughly PhD level across most domains in under a year. That's a steep curve. But what I found more telling than the benchmarks was the infrastructure they're building around it. Wet labs for basic research so their own scientists hit the walls firsthand. An acquisition of Coefficient Bio (acquired by Anthropic) to teach @claudeai how to think like a biotech program manager, not just a bench scientist. The gap between "Claude can answer a biology question" and "Claude can help you run a drug program" is enormous, and they're clearly aware of it. Marc mentioned that 90% of drugs fail in the clinic. Two-thirds of those failures aren't bad science, but patient matching. You have a good target, a good drug, and you can't find who will respond. That's the problem both of them kept circling back to, and it's where causal AI models trained on real perturbation data might actually move the needle. Marc said nobody's pushing a button for a development candidate anytime soon. But Anthropic went from $1B to $30B in revenue in sixteen months. That kind of resource behind this kind of focus is new. It's fun to think of what R&D can look like in the next few months! #SynBioBeta2026 #SyntheticBiology #Biotech #AIxBio
23
99
24
748
132,499
Stephen Hubbard in the Bay retweeted
Excited to integrate @Ginkgo Cloud Lab into Microsoft Discovery! Assuming the frontier model companies let us ask questions about biology🙃 then will need easy interfaces to ordering lab work -- awesome to be building that w/ the team at @Microsoft! techcommunity.microsoft.com/…
1
4
68
2,841